Hanan Foaud1, Sahar Maklad, Faten Mahmoud, Hanaa El-Karaksy. 1. Department of Pediatrics, National Hepatology and Tropical Medicine Research Institute, 7101 El-Kahera Buildings, El-Mokattam, Cairo, 11415, Egypt, hananminaped@gmail.com.
Abstract
BACKGROUND: Occult hepatitis B virus infection (OBI) is a well-recognized clinical entity characterized by the detection of HBV DNA in serum and/or liver in the absence of detectable HBsAg. Diagnosis of OBI requires a sensitive HBV DNA assay. AIM: We aimed at determining the frequency of OBI in infants, born to HBsAg-positive mothers, who received immunoprophylaxis at birth. METHODS: Sixty-four infants and children, born to HBsAg-positive mothers, who received hepatitis B immunoglobulin and HBV vaccine within 48 h after birth, were tested for HBV serological profile and HBV DNA by real-time PCR at least 1 month after last dose of HBV vaccine and not before 6 months of age. RESULTS: The median age of the studied infants and children was 8 months, ranging from 6 to 132 months; 54.7 % were females. HBV DNA was detected in 2 infants. One case had OBI; she was negative for HBsAg, anti-HBc total, HBeAg and was positive for anti-HBs (titer 267 mIU/mL) with low level of viremia (HBV DNA 1.13 x 10(3) IU/mL). Another infant showed immunoprophylaxis failure with positive HBsAg, anti-HBc total, HBeAg, negative anti-HBe and anti-HBs; HBV viral load was 1.7 × 10(8) IU/mL. Both mothers were HBsAg and HBeAg-positive. CONCLUSION: OBI may occur in infants born to HBsAg-positive mothers despite the receipt of immunoprophylaxis. OBI was detected in a low frequency in the present study. Anti-HBs positivity does not exclude OBI.
BACKGROUND:Occult hepatitis B virus infection (OBI) is a well-recognized clinical entity characterized by the detection of HBV DNA in serum and/or liver in the absence of detectable HBsAg. Diagnosis of OBI requires a sensitive HBV DNA assay. AIM: We aimed at determining the frequency of OBI in infants, born to HBsAg-positive mothers, who received immunoprophylaxis at birth. METHODS: Sixty-four infants and children, born to HBsAg-positive mothers, who received hepatitis B immunoglobulin and HBV vaccine within 48 h after birth, were tested for HBV serological profile and HBV DNA by real-time PCR at least 1 month after last dose of HBV vaccine and not before 6 months of age. RESULTS: The median age of the studied infants and children was 8 months, ranging from 6 to 132 months; 54.7 % were females. HBV DNA was detected in 2 infants. One case had OBI; she was negative for HBsAg, anti-HBc total, HBeAg and was positive for anti-HBs (titer 267 mIU/mL) with low level of viremia (HBV DNA 1.13 x 10(3) IU/mL). Another infant showed immunoprophylaxis failure with positive HBsAg, anti-HBc total, HBeAg, negative anti-HBe and anti-HBs; HBV viral load was 1.7 × 10(8) IU/mL. Both mothers were HBsAg and HBeAg-positive. CONCLUSION: OBI may occur in infants born to HBsAg-positive mothers despite the receipt of immunoprophylaxis. OBI was detected in a low frequency in the present study. Anti-HBs positivity does not exclude OBI.
Authors: H W Reesink; C P Engelfriet; G Henn; W R Mayr; G Delage; F Bernier; T Krusius; A Assal; P Gallian; C Corbi; P Morel; B David; P De Micco; H Murokawa; H Yugi; S Hino; K Tadokoro; O Flesland; E Brojer; M Letowska; G Olim; F Nascimento; H Gonçalves; L Castro; M Morais; S L Stezinar; M Alvarez; S Sauleda; R González; C Niederhauser; M Stolz; J-P Allain; S Owusu-Ofori; R Eglin; S Stramer; M Busch; D M Strong; J Epstein; R Biswas Journal: Vox Sang Date: 2008-02 Impact factor: 2.144
Authors: Hanaa M El-Karaksy; Lamiaa M Mohsen; Doa'a A Saleh; Mona S Hamdy; Noha A Yassin; Mohamed Farouk; Mohamed E Salit; Mortada H El-Shabrawi Journal: World J Gastroenterol Date: 2014-12-07 Impact factor: 5.742
Authors: Guglielmo Borgia; Maria Aurora Carleo; Giovanni Battista Gaeta; Ivan Gentile Journal: World J Gastroenterol Date: 2012-09-14 Impact factor: 5.742
Authors: Shuaibu A Hudu; Nabil S Harmal; Mohammed I Saeed; Ahmad S Alshrari; Yasmin A Malik; Mohd T Niazlin; Roshida Hassan; Zamberi Sekawi Journal: Afr Health Sci Date: 2016-09 Impact factor: 0.927